According to the World Health Organization, the number of people in low- and middle-income countries on antiretroviral therapy increased from under one million in 2002 to over six million in 2010. This represents enormous success in expanding access to therapy. It also represents the increasing amount of medicines and other supplies that must be procured, transported, stored, and administered to patients through public health supply chains. Read more »